SuperworthLantern Pharma shares outstanding LTRN
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 12.4M
- On a year earlier
- +15.2%
- more shares
Lantern Pharma had 12.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 15.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 11.2M | +4% |
| FY2024 | 10.8M | −0% |
| FY2023 | 10.8M | −1% |
| FY2022 | 10.9M | −3% |
| FY2021 | 11.2M | +79% |
| FY2020 | 6.2M | +214% |
| FY2019 | 2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 12.4M | +15% | |
| Q1 FY26 | 11.3M | +4% | |
| Q4 FY25 | 11.2M | +4% | |
| Q3 FY25 | 10.8M | +1% | |
| Q2 FY25 | 10.8M | +0% | |
| Q1 FY25 | 10.8M | +0% | |
| Q4 FY24 | 10.8M | −0% | |
| Q3 FY24 | 10.8M | −1% | |
| Q2 FY24 | 10.8M | −1% | |
| Q1 FY24 | 10.7M | −1% | |
| Q4 FY23 | 10.8M | −1% | |
| Q3 FY23 | 10.9M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lantern Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.